Actinium Pharmaceuticals (ATNM) Cash from Investing Activities (2012 - 2026)
Actinium Pharmaceuticals (ATNM) reported Cash from Investing Activities of -$478,000 for Q2 2026.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Cash from Investing Activities (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Actinium Pharmaceuticals' Cash from Investing Activities came in at -$480,000; for FY2025, it was -$104,000.
- By year, Cash from Investing Activities came in at -$11,000 in FY2024, -$153,000 in FY2023, -$366,000 in FY2022 and -$133,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Cash from Investing Activities in data going back to Q1 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Actinium Pharmaceuticals | 47.48 Mn | -132.52 Mn | - | -478,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -478,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Sep 30, 2023 | -30,000.00 |
| Jun 30, 2023 | -47,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -73,000.00 |
| Jun 30, 2022 | -270,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Sep 30, 2021 | -68,000.00 |
| Jun 30, 2021 | -61,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | -245,000.00 |
| Dec 31, 2019 | -5,000.00 |
| Jun 30, 2019 | -7,855.00 |
| Mar 31, 2019 | -51,145.00 |
| Dec 31, 2018 | -10,570.00 |
| Sep 30, 2018 | -58,711.00 |
| Jun 30, 2018 | -19,820.00 |
API Access
Actinium Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();